Examples of using Multiple-dose in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
No accumulation occurs after multiple-dose administration.
Mean(% CV) multiple-dose pharmacokinetic parameters for interferon alfa-2b and.
In addition, Azomyr orodispersible tablets were well tolerated in a multiple-dose trial.
Mean(% CV) multiple-dose pharmacokinetic parameters for Viraferon and ribavirin uc.
Food had no effect on darifenacin pharmacokinetics during multiple-dose administration of prolonged-release tablets.
Multiple-dose pharmacokinetic properties for Viraferon injection and ribavirin na.
No pharmacokinetic interactions were noted between PegIntron and ribavirin in a multiple-dose pharmacokinetic study.
Adults Single-dose and multiple-dose pharmacokinetic studies have been conducted in adult patients undergoing kidney transplantation.
The combination of loratadine/ pseudoephedrine sulphate used in acute and multiple-dose studies, exhibited a low order of toxicity.
The single- and multiple-dose pharmacokinetics of telbivudine were evaluated in healthy subjects and in patients with chronic hepatitis B.
No pharmacokinetic interactions were noted between Rebetol andinterferon alfa-2b in a multiple-dose pharmacokinetic study.
In a multiple-dose pharmacokinetic study conducted with the tablet formulation in healthy adult subjects, four subjects were found to be poor metabolisers of desloratadine.
No pharmacokinetic interactions were noted between Rebetol and peginterferon alfa-2b orinterferon alfa-2b in a multiple-dose pharmacokinetic study.
Systemic absorption of all active substances was determined in multiple-dose studies after placing the veterinary medicinal product into both ear canals of healthy mixed breed dogs.
Lasofoxifene exhibits linear pharmacokinetics over a wide dose range following single-dose(up to 100 mg) and multiple-dose(up to 20 mg once daily) administration.
In a multiple-dose pharmacokinetic study conducted with the tablet formulation in healthy adult subjects, four subjects were found to be poor metabolisers of desloratadine.
Similar pharmacokinetic parameters were observed in a multiple-dose pharmacokinetic study conducted with the syrup formulation in paediatric poor metaboliser subjects 2- to 11-year old diagnosed with allergic rhinitis.
Multiple-dose pharmacokinetic properties for Rebetol capsules and interferon alfa-2b in children and adolescents with chronic hepatitis C between 5 and 16 years of age are summarized in Table 12.
Multiple-dose pharmacokinetic properties for Viraferon injection and ribavirin capsules in children and adolescents with chronic hepatitis C, between 5 and 16 years of age, are summarized no.
In a multiple-dose study in HIV-infected patients dosed with 400 mg of atazanavir once daily with a light meal for 12 weeks, atazanavir was detected in the cerebrospinal fluid and semen.